Skip to main content

Psychedelic trips could soon be part of therapy — here’s what those sessions will look like

In as soon as two years, tripping on mind-altering drugs like MDMA and psilocybin could become a regular part of therapy to treat conditions from depression to post-traumatic stress disorder.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.